Pharvaris (PHVS) Common Equity (2019 - 2026)
Pharvaris' Common Equity was $349.65 trillion in Q2 2026, compared with $208.66 million a year earlier and up 26.4% from the prior quarter.
Powered by 
Analysis
Pharvaris (PHVS) Common Equity (2019 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Pharvaris came in at $306.49 trillion.
- Common Equity shows a five-year compound annual growth rate of 1847.6% (FY2020 to FY2025).
- In earlier years, Common Equity was $289.81 million in FY2024 (-30.2%), $415.43 million in FY2023 (+164.1%), $157.31 million in FY2022 (-35.1%) and $242.54 million in FY2021 (+121.8%).
- The Q2 2026 figure marks the highest quarterly Common Equity since Q1 2024.
- Compared with a year earlier, Common Equity was higher in 1 of the last five quarters, with an average decline of 35.4%.
- The best year-over-year quarter for Common Equity over five years was Q1 2024 (growth of 181.5%); the worst was Q1 2025 (a decline of 100.0%).
- Per Business Quant data, PHVS's Common Equity in the three quarters before Q2 2026 was $276.69 trillion (Q1 2026), $315.78 trillion (Q4 2025) and $365.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Pharvaris | 2.08 Bn | -289,124.32 Bn | 85,072.10 | 349,650.66 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 349,650.66 Bn |
| Mar 31, 2026 | 276,685.12 Bn |
| Dec 31, 2025 | 315,775.13 Bn |
| Sep 30, 2025 | 365.03 Mn |
| Jun 30, 2025 | 208.66 Mn |
| Mar 31, 2025 | 237.03 Mn |
| Dec 31, 2024 | 286.13 Mn |
| Sep 30, 2024 | 325,937.30 Bn |
| Jun 30, 2024 | 358.35 Mn |
| Mar 31, 2024 | 390,187.10 Bn |
| Dec 31, 2023 | 413.21 Mn |
| Sep 30, 2023 | 166,694.31 Bn |
| Jun 30, 2023 | 189.18 Mn |
| Mar 31, 2023 | 138,619.58 Bn |
| Dec 31, 2022 | 152.28 Mn |
| Sep 30, 2022 | 186.70 Mn |
| Jun 30, 2022 | 203.35 Mn |
| Mar 31, 2022 | 214.24 Mn |
| Dec 31, 2021 | 234.46 Mn |
| Sep 30, 2021 | 254.05 Mn |
API Access
Pharvaris Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PHVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PHVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();